Literature DB >> 16838110

The management of ductal carcinoma in situ of the breast: a screened population-based analysis.

Eileen Rakovitch1, Jean-Philippe Pignol, Carole Chartier, Wedad Hanna, Hariette Kahn, John Wong, Verna Mai, Lawrence Paszat.   

Abstract

BACKGROUND: A recent SEER study identified significant variations in the care of women with DCIS, yet several potential confounding variables were not included. We report a patterns of care study of women with DCIS to better understand the gap between evidence-based knowledge and the management of DCIS.
METHODS: We studied all cases of DCIS diagnosed through the Ontario Breast Screening Program from 1991 to 2000. Data was obtained by database linkage and chart abstraction. A logistic regression model using generalized estimating equations to adjust for clustering was used.
RESULTS: About 320,236 women were screened and 727 individuals were diagnosed with DCIS. The rate of mastectomy was 30% and was associated with multifocality (OR: 3.5 [1.7, 7.1], P = 0.0005), tumor size (OR: >2 cm vs. <or=1 cm: 2.7 [1.3, 5.9], P = 0.01), high nuclear grade (OR: 2.4 [1.1, 5.2], P = 0.03) and surgeon's practice pattern. The rate of axillary dissection (AND) decreased from 36% in 1991-1993 to 20% in 1998-2000. AND was associated with mastectomy, year of surgery and hospital volume (OR: 2.7 [1.3, 5.6], P = 0.01). The use of radiation (XRT) following breast-conserving surgery increased from 39% in 1991 to 51% in 2000. XRT was associated with age<70 years, high nuclear grade (OR: 2.7 [1.2, 6.3], P = 0.02) and tumor size > 1 cm (OR: 2.4 [1.3, 4.4], P = 0.006). Half of cases with margins <1 cm did not receive XRT.
CONCLUSIONS: Our study corroborates previous reports on the persistent rates of mastectomy and axillary nodal dissection and the limited use of XRT in the treatment of DCIS.

Entities:  

Mesh:

Year:  2006        PMID: 16838110     DOI: 10.1007/s10549-006-9302-0

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  18 in total

1.  Canadian breast cancer guidelines are as effective as possible under the circumstances.

Authors:  Eva Grunfeld
Journal:  CMAJ       Date:  2007-03-13       Impact factor: 8.262

2.  Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ.

Authors:  Caprice C Greenberg; Laurel A Habel; Melissa E Hughes; Larissa Nekhlyudov; Ninah Achacoso; Luana Acton; Deborah Schrag; Wei Jiang; Stephen Edge; Jane C Weeks; Rinaa S Punglia
Journal:  Ann Surg Oncol       Date:  2014-05-24       Impact factor: 5.344

3.  Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).

Authors:  Icro Meattini; Marta Scorsetti; Fiorenza De Rose; Maria Carmen De Santis; Bruno Meduri; Ciro Franzese; Davide Franceschini; Pierfrancesco Franco; Nadia Pasinetti; Valentina Lancellotta; Patrizia Giacobazzi; Eliana La Rocca; Elisa D'Angelo; Laura Lozza; Lorenzo Livi
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-02       Impact factor: 4.553

4.  Radiation therapy for ductal carcinoma in situ: a decision analysis.

Authors:  Rinaa S Punglia; Harold J Burstein; Jane C Weeks
Journal:  Cancer       Date:  2011-06-30       Impact factor: 6.860

5.  Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons.

Authors:  Andrew W Dick; Melony S Sorbero; Gretchen M Ahrendt; James A Hayman; Heather T Gold; Linda Schiffhauer; Azadeh Stark; Jennifer J Griggs
Journal:  J Natl Cancer Inst       Date:  2011-01-03       Impact factor: 13.506

6.  Correlation of histopathologic features of ductal carcinoma in situ of the breast with the oncotype DX DCIS score.

Authors:  Adriana Knopfelmacher; Jana Fox; Yungtai Lo; Nella Shapiro; Susan Fineberg
Journal:  Mod Pathol       Date:  2015-06-26       Impact factor: 7.842

7.  Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.

Authors:  Nils D Arvold; Rinaa S Punglia; Melissa E Hughes; Wei Jiang; Stephen B Edge; Sara H Javid; Christine Laronga; Joyce C Niland; Richard L Theriault; Jane C Weeks; Yu-Ning Wong; Sandra J Lee; Michael J Hassett
Journal:  Cancer       Date:  2012-06-06       Impact factor: 6.860

8.  Modeling the effectiveness of initial management strategies for ductal carcinoma in situ.

Authors:  Djøra I Soeteman; Natasha K Stout; Elissa M Ozanne; Caprice Greenberg; Michael J Hassett; Deborah Schrag; Rinaa S Punglia
Journal:  J Natl Cancer Inst       Date:  2013-05-03       Impact factor: 13.506

9.  Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community.

Authors:  Michael J Hassett; Wei Jiang; Laurel A Habel; Larissa Nekhlyudov; Ninah Achacoso; Luana Acton; Stuart J Schnitt; Deb Schrag; Rinaa S Punglia
Journal:  Breast Cancer Res Treat       Date:  2016-02-03       Impact factor: 4.872

10.  High and intermediate grade ductal carcinoma in-situ of the breast: a comparison of pathologic features in core biopsies and excisions and an evaluation of core biopsy features that may predict a close or positive margin in the excision.

Authors:  Oluwole Fadare; Nathan F Clement; Mohiedean Ghofrani
Journal:  Diagn Pathol       Date:  2009-08-19       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.